Description
Enzalutamide Capsules offer a clinically approved solution for advanced prostate cancer treatment.
- Indication: Primarily used for patients diagnosed with metastaticcastration-resistant prostate cancer after progression following androgen deprivation therapy.
- Mechanism of Action: Enzalutamide binds to androgen receptors, blockingthem from interacting with androgens, ultimately inhibiting the cancer cell cycle and inducing cell death.
- Dosage and Administration: Typically administered orally, once daily, with or without food, making it convenient for the patient’ s routine.
- Key Benefits: Provides a targeted approach to manage advanced prostatecancer, contributing to prolonged patient survival and improved quality of life.
- Precautions: Regular monitoring by healthcare professionals is advised, as side effects may include fatigue, hypertension, or decreased appetite.
- Storage: Store at room temperature away from moisture and direct sunlightto maintain product integrity.
